Full Press Release Details
Sundial Growers Inc.
Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited - expressed in thousands of Canadian dollars)
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Financial Position
(Unaudited - expressed in thousands of Canadian dollars)
| As at | Note | March 31, 2021 | December 31, 2020 (1) | ||||
| Assets | |||||||
| Current Assets | |||||||
| Cash and cash equivalents | 873,445 | 60,376 | |||||
| Restricted cash | 100 | 5,333 | |||||
| Marketable securities | 6 | 33,582 | - | ||||
| Accounts receivable | 7 | 9,350 | 15,898 | ||||
| Biological assets | 8 | 2,835 | 3,531 | ||||
| Inventory | 9 | 32,837 | 25,613 | ||||
| Prepaid expenses and deposits | 5,097 | 4,622 | |||||
| Assets held for sale | 2,998 | 2,998 | |||||
| 960,244 | 118,371 | ||||||
| Non-current assets | |||||||
| Long-term deposits | 7,981 | 2,633 | |||||
| Property, plant and equipment | 10 | 114,039 | 116,928 | ||||
| Intangible assets | 11 | 4,974 | 5,063 | ||||
| Investments | 12 | 62,451 | 51,876 | ||||
| Total assets | 1,149,689 | 294,871 | |||||
| Liabilities | |||||||
| Current liabilities | |||||||
| Accounts payable and accrued liabilities | 22,701 | 23,308 | |||||
| Current portion of lease obligations | 416 | 409 | |||||
| Derivative warrants | 13 | 73,810 | 428 | ||||
| 96,927 | 24,145 | ||||||
| Non-current liabilities | |||||||
| Lease obligations | 924 | 1,031 | |||||
| Total liabilities | 97,851 | 25,176 | |||||
| Shareholders' equity | |||||||
| Share capital | 14(b) | 1,675,595 | 762,046 | ||||
| Warrants | 14(c) | 6,138 | 6,138 | ||||
| Contributed surplus | 60,370 | 59,344 | |||||
| Contingent consideration | 2,279 | 2,279 | |||||
| Accumulated deficit (1) | (692,544 | ) | (558,128 | ) | |||
| Total shareholders' equity | 1,051,838 | 271,679 | |||||
| Non-controlling interest (1) | - | (1,984 | ) | ||||
| Total liabilities and shareholders' equity | 1,149,689 | 294,871 |
Commitments (note 24)
Subsequent events (note 25)
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Loss and Comprehensive Loss
(Unaudited - expressed in thousands of Canadian dollars, except per share amounts)
| Three months ended March 31 | ||||||||||
| Note | 2021 | 2020 | ||||||||
| Gross revenue | 16 | 11,748 | 16,590 | |||||||
| Excise taxes | 1,857 | 2,584 | ||||||||
| Net revenue | 9,891 | 14,006 | ||||||||
| Cost of sales | 9 | 11,445 | 13,507 | |||||||
| Inventory obsolescence | 9 | 1,754 | 7,715 | |||||||
| Gross margin before fair value adjustments | (3,308 | ) | (7,216 | ) | ||||||
| Change in fair value of biological assets | 8 | (94 | ) | 6,415 | ||||||
| Change in fair value realized through inventory | 9 | (50 | ) | (9,692 | ) | |||||
| Gross margin | (3,452 | ) | (10,493 | ) | ||||||
| Interest and fee revenue | 17 | 2,849 | - | |||||||
| Investment revenue | 17 | 12,900 | - | |||||||
| General and administrative | 7,093 | 10,608 | ||||||||
| Sales and marketing | 950 | 1,792 | ||||||||
| Research and development | 235 | 307 | ||||||||
| Depreciation and amortization | 10,11 | 1,058 | 657 | |||||||
| Share-based compensation | 15 | 3,456 | 795 | |||||||
| Restructuring costs | - | 2,719 | ||||||||
| Asset impairment | - | 5,659 | ||||||||
| Government subsidies | 18 | (2,180 | ) | - | ||||||
| Income (loss) from operations | 1,685 | (33,030 | ) | |||||||
| Transaction costs | (3,648 | ) | (1,101 | ) | ||||||
| Finance costs | 19 | (51 | ) | (5,982 | ) | |||||
| Change in estimate of fair value of derivative warrants | 13 | (129,944 | ) | - | ||||||
| Foreign exchange gain (loss) | (440 | ) | 1,554 | |||||||
| Gain (loss) on disposition of PP&E | (117 | ) | 610 | |||||||
| Other expenses | 12 | (1,930 | ) | - | ||||||
| Loss before income tax | (134,445 | ) | (37,949 | ) | ||||||
| Net loss from continuing operations | (134,445 | ) | (37,949 | ) | ||||||
| Net loss from discontinued operations | 4 | - | (6,034 | ) | ||||||
| Net loss | (134,445 | ) | (43,983 | ) | ||||||
| Gain on translation of foreign operations | - | 1,693 | ||||||||
| Comprehensive loss | (134,445 | ) | (42,290 | ) | ||||||
| Net loss from continuing operations attributable to: | ||||||||||
| Sundial Growers Inc. | (134,416 | ) | (37,861 | ) | ||||||
| Non-controlling interest | (29 | ) | (88 | ) | ||||||
| (134,445 | ) | (37,949 | ) | |||||||
| Net loss attributable to: | ||||||||||
| Sundial Growers Inc. | (134,416 | ) | (43,895 | ) | ||||||
| Non-controlling interest | (29 | ) | (88 | ) | ||||||
| (134,445 | ) | (43,983 | ) | |||||||
| Comprehensive loss attributable to: | ||||||||||
| Sundial Growers Inc. | (134,416 | ) | (42,202 | ) | ||||||
| Non-controlling interest | (29 | ) | (88 | ) | ||||||
| (134,445 | ) | (42,290 | ) | |||||||
| Net loss per common share attributable to Sundial Growers Inc. | ||||||||||
| Basic and diluted | 20 | $ | (0.09 | ) | $ | (0.41 | ) |
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity
(Unaudited - expressed in thousands of Canadian dollars)
| Note | Share capital | Warrants | Contributed surplus | Contingent consideration | Accumulated deficit (1) | Accumulated other comprehensive income | Non- controlling interest (1) | Total equity | |||||||||||||||||
| Balance at December 31, 2020 (1) | 762,046 | 6,138 | 59,344 | 2,279 | (558,128 | ) | - | (1,984 | ) | 269,695 | |||||||||||||||
| Net loss | - | - | - | - | (134,416 | ) | - | (29 | ) | (134,445 | ) | ||||||||||||||
| Loss of control of subsidiary | 12 | - | - | - | - | - | - | 2,013 | 2,013 | ||||||||||||||||
| Share issuances | 14(b) | 647,315 | - | - | - | - | - | - | 647,315 | ||||||||||||||||
| Share issuance costs | 14(b) | (13,483 | ) | - | - | - | - | - | - | (13,483 | ) | ||||||||||||||
| Derivative warrants exercised | 13 | 277,136 | - | - | - | - | - | - | 277,136 | ||||||||||||||||
| Share-based compensation | 15 | 1 | - | 3,455 | - | - | - | - | 3,456 | ||||||||||||||||
| Employee awards exercised | 2,580 | - | (2,429 | ) | - | - | - | - | 151 | ||||||||||||||||
| Balance at March 31, 2021 | 1,675,595 | 6,138 | 60,370 | 2,279 | (692,544 | ) | - | - | 1,051,838 |
| Note | Share capital | Warrants | Contributed surplus | Contingent consideration | Accumulated deficit | Accumulated other comprehensive income | Non- controlling interest | Total equity | |||||||||||||||||
| Balance at December 31, 2019 | 509,654 | 27,831 | 30,192 | 2,279 | (360,338 | ) | 6,866 | 4,714 | 221,198 | ||||||||||||||||
| Net loss | - | - | - | - | (43,895 | ) | - | (88 | ) | (43,983 | ) | ||||||||||||||
| Other comprehensive income | - | - | - | - | - | 1,693 | - | 1,693 | |||||||||||||||||
| Share issuances | 610 | - | - | - | - | - | - | 610 | |||||||||||||||||
| Share-based compensation | 15 | 50 | - | 1,186 | - | - | - | - | 1,236 | ||||||||||||||||
| Balance at March 31, 2020 | 510,314 | 27,831 | 31,378 | 2,279 | (404,233 | ) | 8,559 | 4,626 | 180,754 |
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Cash Flows
(Unaudited - expressed in thousands of Canadian dollars)
| Three months ended March 31 | ||||||||||
| Note | 2021 | 2020 | ||||||||
| Cash provided by (used in): | ||||||||||
| Operating activities | ||||||||||
| Net loss from continuing operations for the period | (134,445 | ) | (37,949 | ) | ||||||
| Items not involving cash: | ||||||||||
| Change in fair value of biological assets | 94 | (6,415 | ) | |||||||
| Share-based compensation | 15 | 3,456 | 795 | |||||||
| Depreciation and amortization | 10,11 | 2,407 | 2,923 | |||||||
| (Gain) loss on disposition of PP&E | 117 | (610 | ) | |||||||
| Inventory obsolescence | 9 | 1,754 | 7,715 | |||||||
| Finance costs | 19 | 23 | 1,916 | |||||||
| Change in estimate of fair value of derivative warrants | 13 | 129,944 | - | |||||||
| Unrealized foreign exchange (gain) loss | 1,905 | (1,769 | ) | |||||||
| Asset impairment | - | 5,659 | ||||||||
| Other expenses | 12 | 1,862 | - | |||||||
| Gain on disposition of marketable securities | 6,17 | (8,019 | ) | - | ||||||
| Unrealized gain on marketable securities | 6 | (4,881 | ) | - | ||||||
| Additions to marketable securities | 6 | (36,740 | ) | - | ||||||
| Proceeds from disposal of marketable securities | 6 | 16,058 | - | |||||||
| Change in non-cash working capital | (7,901 | ) | 10,225 | |||||||
| Net cash used in operating activities from continuing operations | (34,366 | ) | (17,510 | ) | ||||||
| Net cash provided by operating activities from discontinued operations | 4 | - | 4,064 | |||||||
| Net cash used in operating activities | (34,366 | ) | (13,446 | ) | ||||||
| Investing activities | ||||||||||
| Additions to property, plant and equipment | 10 | (119 | ) | (1,676 | ) | |||||
| Additions to investments | 12 | (10,560 | ) | - | ||||||
| Proceeds from disposal of PP&E | 10 | 60 | 2,100 | |||||||
| Change in non-cash working capital | (240 | ) | (8,061 | ) | ||||||
| Net cash used in investing activities from continuing operations | (10,859 | ) | (7,637 | ) | ||||||
| Net cash used in investing activities from discontinued operations | 4 | - | (4,946 | ) | ||||||
| Net cash used in investing activities | (10,859 | ) | (12,583 | ) | ||||||
| Financing activities | ||||||||||
| Change in restricted cash | 5,233 | 10,495 | ||||||||
| Repayment of Syndicated Credit Agreement | - | (10,000 | ) | |||||||
| Payments on lease obligations | (123 | ) | (119 | ) | ||||||
| Proceeds from issuance of shares and registered offerings, net of costs | 14(b) | 735,088 | - | |||||||
| Proceeds from exercise of derivative warrants | 13 | 119,318 | - | |||||||
| Proceeds from exercise of employee warrants | 15 | 151 | - | |||||||
| Change in non-cash working capital | 579 | (207 | ) | |||||||
| Net cash provided by financing activities from continuing operations | 860,246 | 169 | ||||||||
| Net cash used in financing activities from discontinued operations | 4 | - | 122 | |||||||
| Net cash provided by financing activities | 860,246 | 291 | ||||||||
| Effect of exchange rate changes on cash held in foreign currency | (1,952 | ) | 1,558 | |||||||
| Change in cash and cash equivalents | 813,069 | (24,180 | ) | |||||||
| Cash and cash equivalents, beginning of period | 60,376 | 45,337 | ||||||||
| Cash and cash equivalents, end of period | 873,445 | 21,157 | ||||||||
| Cash interest paid | - | 1,195 |
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Sundial Growers Inc. ("Sundial" or the "Company") was incorporated under the Business Corporations Act (Alberta) on August 19, 2006.
The Company's head office is located at 300, 919 11th Avenue SW, Calgary, Alberta, Canada.
The principal activities of the Company are the production, distribution and sale of cannabis in Canada pursuant to the Cannabis Act and the deployment of capital to investment opportunities. The Cannabis Act regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada.
Sundial and its subsidiaries currently operate solely in Canada. Through its joint venture SunStream Bancorp Inc. (note 25) the Company also provides growth capital and a strategic support platform that pursues indirect investment opportunities in the global cannabis sector, where lawful as well as other investment opportunities. The Company also makes portfolio investments in debt and equity securities where deemed strategic.
The Company's common shares trade on the Nasdaq Capital Market ("Nasdaq") under the ticker symbol "SNDL".
The global impact of COVID-19 has contributed to a great deal of uncertainty as to the health of the global economy. The Company has implemented several new pandemic-related procedures and protocols at its facilities, including enhanced screening measures, enhanced cleaning and sanitation processes and frequency, encouraging social distancing measures and directing employees to work from home if possible. The Company believes that it can maintain safe operations with these pandemic-related procedures and protocols in place.
The potential impact that COVID-19 will have on the Company's business or financial results cannot be reasonably estimated at this time. However, any shutdowns requested or mandated by government authorities in response to the outbreak of COVID-19 that may affect the Company, its suppliers, distribution channels or customers may have a material impact to the Company's planned operations.
The condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard 34 - Interim Financial Reporting as issued by the International Accounting Standards Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). The condensed consolidated interim financial statements were prepared using the same accounting policies and methods as those disclosed in the audited consolidated financial statements for the year ended December 31, 2020, except as described in note 3. The condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements for the Company for the year ended December 31, 2020 which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the IASB.
These condensed consolidated interim financial statements were approved and authorized for issue by the Board of Directors ("Board") on May 11, 2021.
These condensed consolidated interim financial statements have been prepared on a historical cost basis, except for biological assets and certain financial instruments which are measured at fair value with changes in fair value recorded in earnings.
These condensed consolidated interim financial statements are presented in Canadian dollars, which is the functional and presentation currency of the Company and its Canadian based subsidiaries.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Subsidiaries are entities controlled by the Company. Control exists when the Company has the power, directly and indirectly, to govern the financial and operating policies of an entity and be exposed to the variable returns from its activities. The financial statements of subsidiaries are included in these condensed consolidated interim financial statements from the date that control commences until the date that control ceases.
| Subsidiaries | Jurisdiction of incorporation | Percentage ownership | ||
| Sprout Technologies Inc. | Alberta, Canada | 100 | % | |
| KamCan Products Inc. | British Columbia, Canada | 100 | % | |
| 2011296 Alberta Inc. | Alberta, Canada | 100 | % | |
| Sundial Deutschland GmbH | Germany | 100 | % | |
| Sundial Portugal, Unipessoal LDA | Portugal | 100 | % | |
| 2657408 Ontario Inc. | Ontario, Canada | 100 | % | |
| NGBA-BC Holdings Ltd. | British Columbia, Canada | 100 | % | |
| Sundial Insurance (Bermuda) Ltd. | Bermuda | 100 | % |
The accounting policies, critical accounting judgements and significant estimates used in the preparation of the Company's audited consolidated financial statements for the year ended December 31, 2020 have been applied in the preparation of these condensed consolidated interim financial statements except as described below.
When the Company loses control over a subsidiary, it derecognizes the assets and liabilities of the subsidiary, and any related non-controlling interest and other components of equity. Any resulting gain or loss is recognized in profit or loss. Any interest retained in the former subsidiary is measured at fair value when control is lost.
Interests in equity-accounted investees
The Company's interest in equity-accounted investees is comprised of an interest in an associate.
Associates are those entities in which the Company has significant influence, but not control or joint control, over the financial and operating policies.
Interests in associates are accounted for using the equity method. They are initially recognized at cost, which includes transaction costs. Subsequent to initial recognition, the consolidated financial statements include the Company's share of the profit or loss and OCI of equity-accounted investees, until the date on which significant influence or joint control ceases.
On May 15, 2020, the Company entered into an agreement to sell all of the outstanding shares of Project Seed Topco ("Bridge Farm") which closed on June 5, 2020.
The comparative statement of loss and comprehensive loss and statement of cash flows has been re-presented to show the discontinued operation separately from continuing operations.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Results of discontinued operations
| Three months ended March 31 | ||||||||
| 2021 | 2020 | |||||||
| Gross revenue | - | 9,031 | ||||||
| Net revenue | - | 9,031 | ||||||
| Cost of sales | - | 6,982 | ||||||
| Gross margin before fair value adjustments | - | 2,049 | ||||||
| Change in fair value of biological assets | - | 668 | ||||||
| Gross margin | - | 2,717 | ||||||
| General and administrative | - | 3,785 | ||||||
| Sales and marketing | - | 488 | ||||||
| Depreciation and amortization | - | 1,590 | ||||||
| Foreign exchange | - | 1,724 | ||||||
| Share-based compensation | - | 441 | ||||||
| Loss from operations | - | (5,311 | ) | |||||
| Finance costs | - | (192 | ) | |||||
| Loss on contingent consideration | - | (761 | ) | |||||
| Loss before income tax | - | (6,264 | ) | |||||
| Income tax recovery | - | 230 | ||||||
| Net loss (1) | - | (6,034 | ) |
Late in the fourth quarter of 2020 the Company began the deployment of capital toward strategic investments. The Company developed an internal capital program to evaluate these and potential future investments, which the Company viewed as a new and separate business line from its cannabis operations.
Based on the allocation of the Company's resources by the chief operating decision maker and the information used to analyze the performance of the business, the Company concluded that beginning in Q1 2021, it had two operating segments: cannabis and investments. For the three months ended March 31, 2020, there was only one reportable segment and therefore no comparative segment information.
The Company's reportable segments are organized by business line and are comprised of two reportable operating segments: cannabis operations and investment operations. Cannabis operations include the cultivation, distribution and sale of cannabis for the adult-use market and medical markets in Canada. Investment operations include the deployment of capital to investment opportunities. Certain overhead expenses not directly attributable to either the cannabis operations segment or investment operations segment are reported in a third segment referred to as "Corporate".
| As at March 31, 2021 | Cannabis | Investments | Corporate | Total | ||||||||||||
| Total assets | 319,213 | 827,476 | 3,000 | 1,149,689 | ||||||||||||
| Three months ended March 31, 2021 | ||||||||||||||||
| Net revenue | 9,891 | 15,749 | - | 25,640 | ||||||||||||
| Depreciation and amortization | 954 | - | 104 | 1,058 | ||||||||||||
| Gross margin | (3,452 | ) | 15,749 | - | 12,297 | |||||||||||
| Earnings (loss) before tax | (9,172 | ) | 14,300 | (139,573 | ) | (134,445 | ) |
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
| As at | March 31, 2021 | December 31, 2020 | ||||
| Balance, beginning of year | - | - | ||||
| Additions | 36,740 | - | ||||
| Dispositions | (8,039 | ) | - | |||
| Change in fair value recognized in profit or loss | 4,881 | - | ||||
| Balance, end of period | 33,582 | - |
During the three months ended March 31, 2021, proceeds of $16.1 million were received for dispositions of marketable securities and a gain on disposition of $8.0 million was recognized (note 17).
Marketable securities have been designated as Fair Value Through Profit or Loss ("FVTPL") (note 21).
| As at | March 31, 2021 | December 31, 2020 | ||||
| Trade receivables | 8,502 | 15,786 | ||||
| Other receivables | 848 | 112 | ||||
| 9,350 | 15,898 |
The Company has calculated expected credit losses ("ECLs") based on lifetime expected credit losses, taking into consideration historical credit loss experience and financial factors specific to the debtors and general economic conditions. Refer to note 21 for credit risk disclosures.
The Company's biological assets consist of cannabis plants in various stages of vegetation, including plants which have not been harvested. The change in carrying value of biological assets are as follows:
| As at | March 31, 2021 | December 31, 2020 | ||||
| Balance, beginning of year | 3,531 | 14,309 | ||||
| Increase in biological assets due to capitalized costs | 6,992 | 39,957 | ||||
| Net change in fair value of biological assets | (94 | ) | 6,496 | |||
| Transferred to inventory upon harvest | (7,594 | ) | (54,388 | ) | ||
| Disposition of Bridge Farm (note 4) | - | (2,831 | ) | |||
| Foreign currency translation | - | (12 | ) | |||
| Balance, end of period | 2,835 | 3,531 |
Biological assets are valued in accordance with IAS 41 and are presented at their fair value less costs to sell up to the point of harvest. This is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price less costs to produce and sell per gram.
The fair value measurements for biological assets have been categorized as Level 3 fair values based on the inputs to the valuation technique used. The Company's method of accounting for biological assets attributes value accretion on a straight-line basis throughout the life of the biological asset from initial cloning to the point of harvest.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Management believes the most significant unobservable inputs and their impact on fair value of biological assets are as follows:
| Assumption | Input | Weighted average input | Effect of 10% change ($000s) | ||||||||||
| March 31 2021 | December 31 2020 | March 31 2021 | December 31 2020 | ||||||||||
| Yield per square foot of growing space (1) | Grams | 43 | 45 | 277 | 347 | ||||||||
| Average net selling price (2) | $/gram | 4.83 | 5.13 | 835 | 1,022 | ||||||||
| After harvest cost to complete and sell | $/gram | 1.39 | 1.32 | 240 | 291 |
These estimates are subject to volatility in market prices and several uncontrollable factors, which could significantly affect the fair value of biological assets in future periods.
The Company estimates the harvest yields for cannabis at various stages of growth. As at March 31, 2021, it is estimated that the Company's biological assets will yield approximately 5,189 kilograms (December 31, 2020 - 5,507 kilograms) of dry cannabis when harvested. During the three months ended March 31, 2021, the Company harvested 5,387 kilograms of dry cannabis (three months ended March 31, 2020 - 10,254 kilograms).
The Company's estimates are, by their nature, subject to change and differences from the anticipated yield will be reflected in the net change in fair value of biological assets in future periods.
| As at | March 31, 2021 | December 31, 2020 | ||||
| Harvested cannabis | 27,979 | 20,358 | ||||
| Cannabis supplies and consumables | 4,858 | 5,255 | ||||
| 32,837 | 25,613 |
During the three months ended March 31, 2021, inventories of $11.4 million were recognized as an expense (three months ended March 31, 2020 - $13.5 million). During the three months ended March 31, 2021, the Company recognized inventory write downs of $1.8 million (three months ended March 31, 2020 - $14.4 million), of which $1.8 million (three months ended March 31, 2020 - $7.7 million) was recognized as an excess and obsolete inventory provision, and $0.0 million (three months ended March 31, 2020 - $6.7 million) was included in the change in fair value realized through inventory as the fair value component of the excess and obsolete inventory provision.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
| Land and buildings | Production facilities | Equipment | Right of use assets | Construction in progress ("CIP") | Total | |||||||||||||
| Cost | ||||||||||||||||||
| Balance at December 31, 2020 | 8,640 | 152,937 | 28,894 | 1,894 | 8,819 | 201,184 | ||||||||||||
| Additions | - | (263 | ) | (131 | ) | - | - | (394 | ) | |||||||||
| Dispositions | - | - | - | (128 | ) | (177 | ) | (305 | ) | |||||||||
| Balance at March 31, 2021 | 8,640 | 152,674 | 28,763 | 1,766 | 8,642 | 200,485 | ||||||||||||
| Accumulated amortization and impairment | ||||||||||||||||||
| Balance at December 31, 2020 | - | 69,364 | 8,500 | 571 | 5,821 | 84,256 | ||||||||||||
| Depreciation | - | 928 | 1,286 | 104 | - | 2,318 | ||||||||||||
| Dispositions | - | - | - | (128 | ) | - | (128 | ) | ||||||||||
| Balance at March 31, 2021 | - | 70,292 | 9,786 | 547 | 5,821 | 86,446 | ||||||||||||
| Net book value | ||||||||||||||||||
| Balance at December 31, 2020 | 8,640 | 83,573 | 20,394 | 1,323 | 2,998 | 116,928 | ||||||||||||
| Balance at March 31, 2021 | 8,640 | 82,382 | 18,977 | 1,219 | 2,821 | 114,039 |
During the three months ended March 31, 2021, depreciation expense of $1.3 million was capitalized to biological assets and inventory (three months ended March 31, 2020 - $2.3 million).
During the three months ended March 31, 2021, the credit to additions relates to the recovery of construction holdbacks and a grant receivable.
| Brands and trademarks | Patents | Total | |||||||
| Cost | |||||||||
| Balance at December 31, 2020 and March 31, 2021 | 5,445 | 13,551 | 18,996 | ||||||
| Accumulated amortization and impairment | |||||||||
| Balance at December 31, 2020 | 382 | 13,551 | 13,933 | ||||||
| Depreciation | 89 | - | 89 | ||||||
| Balance at March 31, 2021 | 471 | 13,551 | 14,022 | ||||||
| Net book value | |||||||||
| Balance at December 31, 2020 | 5,063 | - | 5,063 | ||||||
| Balance at March 31, 2021 | 4,974 | - | 4,974 |
Brands and trademarks consist of intellectual property purchased from Sun 8 Holdings Inc. with a useful life of 15 years and other intellectual property with a useful life of 12 years.
Sundial Growers Inc.